| Methodological guidelines to study extracellular vesicles FAW Coumans, AR Brisson, EI Buzas, F Dignat-George, EEE Drees, ... Circulation research 120 (10), 1632-1648, 2017 | 479 | 2017 |
| Ticagrelor–toward more efficient platelet inhibition and beyond MJ Kubisa, MP Jezewski, A Gasecka, JM Siller-Matula, M Postuła Therapeutics and clinical risk management 14, 129, 2018 | 51 | 2018 |
| Thrombotic complications in patients with COVID-19: pathophysiological mechanisms, diagnosis, and treatment A Gąsecka, JA Borovac, RA Guerreiro, M Giustozzi, W Parker, D Caldeira, ... Cardiovascular drugs and therapy, 1-15, 2020 | 39 | 2020 |
| TMA, a forgotten uremic toxin, but not TMAO, is involved in cardiovascular pathology K Jaworska, D Hering, G Mosieniak, A Bielak-Zmijewska, M Pilz, ... Toxins 11 (9), 490, 2019 | 37 | 2019 |
| Hollow organosilica beads as reference particles for optical detection of extracellular vesicles Z Varga, E Van der Pol, M Pálmai, R Garcia‐Diez, C Gollwitzer, ... Journal of Thrombosis and Haemostasis 16 (8), 1646-1655, 2018 | 35 | 2018 |
| Platelet extracellular vesicles as biomarkers for arterial thrombosis A Gasecka, AN Böing, KJ Filipiak, R Nieuwland Platelets 28 (3), 228-234, 2017 | 31 | 2017 |
| Cell-derived microvesicles in cardiovascular diseases and antiplatelet therapy monitoring—A lesson for future trials? Current evidence, recent progresses and perspectives of … M Tomaniak, A Gąsecka, KJ Filipiak International journal of cardiology 226, 93-102, 2017 | 22 | 2017 |
| Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel A Gasecka, R Nieuwland, M Budnik, F Dignat‐George, C Eyileten, ... Journal of thrombosis and haemostasis 18 (3), 609-623, 2020 | 18 | 2020 |
| Platelet-derived extracellular vesicles A Gasecka, R Nieuwland, PRM Siljander Platelets, 401-416, 2019 | 16 | 2019 |
| P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets: Preliminary results A Gasecka, R Nieuwland, E van der Pol, N Hajji, A Ćwiek, K Pluta, ... Cardiology Journal, 2018 | 15* | 2018 |
| Can prasugrel decrease the extent of periprocedural myocardial injury during elective percutaneous coronary intervention? M Tomaniak, Ł Kołtowski, J Kochman, Z Huczek, A Rdzanek, A Pietrasik, ... Arch. Intern. Med 127, 730-740, 2017 | 13 | 2017 |
| Early biomarkers of neurodegenerative and neurovascular disorders in diabetes A Gasecka, D Siwik, M Gajewska, MJ Jaguszewski, T Mazurek, KJ Filipiak, ... Journal of Clinical Medicine 9 (9), 2807, 2020 | 10 | 2020 |
| Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction A Gasecka, R Nieuwland, M Budnik, F Dignat-George, C Eyileten, ... Platelets 31 (1), 26-32, 2020 | 8 | 2020 |
| Impaired microcirculation function in COVID-19 and implications for potential therapies A Gąsecka, KJ Filipiak, MJ Jaguszewski Cardiology journal 27 (5), 485-488, 2020 | 8 | 2020 |
| Switching between P2Y12 antagonists–From bench to bedside A Gasecka, M Konwerski, J Pordzik, A Soplińska, KJ Filipiak, ... Vascular pharmacology 115, 1-12, 2019 | 5 | 2019 |
| Dysregulations of miRNAs and galectin-3 may underlie left ventricular dilatation in patients with systolic heart failure M Tomaniak, G Sygitowicz, KJ Filipiak, O Błaszczyk, Ł Kołtowski, ... Kardiologia Polska (Polish Heart Journal) 76 (6), 1012-1014, 2018 | 5 | 2018 |
| Extracellular vesicles in post-infarct ventricular remodelling A Gasecka, E van der Pol, R Nieuwland, E Stępień Kardiologia Polska (Polish Heart Journal), 2017 | 5 | 2017 |
| Post-COVID-19 heart syndrome A Gasecka, M Pruc, K Kukula, N Gilis-Malinowska, KJ Filipiak, ... Cardiology journal 28 (2), 353-354, 2021 | 4 | 2021 |
| Correlation between takotsubo cardiomyopathy and SARS-CoV-2 infection L Szarpak, KJ Filipiak, A Gasecka, M Pruc, A Drozd, MJ Jaguszewski Medical hypotheses 146, 110454, 2021 | 4 | 2021 |
| Inflammatory state does not affect the antiplatelet efficacy of potent P2Y12 inhibitors in ACS BS Biesinger, A Gasecka, T Perkmann, J Wojta, M Lesiak, M Grygier, ... Platelets, 1-9, 2020 | 4 | 2020 |
Krzysztof J. FilipiakWarszawski Uniwersytet MedycznyVerified email at wum.edu.pl
